Report Detail

Pharma & Healthcare Global OTC Anti-Infective Medications Market Growth (Status and Outlook) 2021-2026

  • RnM4350275
  • |
  • 29 October, 2021
  • |
  • Global
  • |
  • 103 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

According to this latest study, the 2021 growth of OTC Anti-Infective Medications will have significant change from previous year. By the most conservative estimates of global OTC Anti-Infective Medications market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the OTC Anti-Infective Medications market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of OTC Anti-Infective Medications market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Antifungals
Antiseptic
Antiparasitics

Segmentation by sales channel: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospital Pharmacies
Drug Stores
E-Commerce

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
NanoViricides
Novabay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global OTC Anti-Infective Medications Market Size 2016-2026
    • 2.1.2 OTC Anti-Infective Medications Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 OTC Anti-Infective Medications Segment by Type
    • 2.2.1 Antifungals
    • 2.2.2 Antifungals
    • 2.2.3 Antiparasitics
  • 2.3 OTC Anti-Infective Medications Market Size by Type
    • 2.3.1 Global OTC Anti-Infective Medications Market Size CAGR by Type
    • 2.3.2 Global OTC Anti-Infective Medications Market Size Market Share by Type (2016-2021)
  • 2.4 OTC Anti-Infective Medications Segment by Sales Channel
    • 2.4.1 Hospital Pharmacies
    • 2.4.2 Drug Stores
    • 2.4.3 E-Commerce
  • 2.5 OTC Anti-Infective Medications Market Size by Sales Channel
    • 2.5.1 Global OTC Anti-Infective Medications Market Size CAGR by Sales Channel
    • 2.5.2 Global OTC Anti-Infective Medications Market Size Market Share by Sales Channel (2016-2021)

3 OTC Anti-Infective Medications Market Size by Players

  • 3.1 OTC Anti-Infective Medications Market Size Market Share by Players
    • 3.1.1 Global OTC Anti-Infective Medications Revenue by Players (2019-2021E)
    • 3.1.2 Global OTC Anti-Infective Medications Revenue Market Share by Players (2019-2021E)
  • 3.2 Global OTC Anti-Infective Medications Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 OTC Anti-Infective Medications by Regions

  • 4.1 OTC Anti-Infective Medications Market Size by Regions (2016-2021)
  • 4.2 Americas OTC Anti-Infective Medications Market Size Growth (2016-2021)
  • 4.3 APAC OTC Anti-Infective Medications Market Size Growth (2016-2021)
  • 4.4 Europe OTC Anti-Infective Medications Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa OTC Anti-Infective Medications Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas OTC Anti-Infective Medications Market Size by Country (2016-2021)
  • 5.2 Americas OTC Anti-Infective Medications Market Size by Type (2016-2021)
  • 5.3 Americas OTC Anti-Infective Medications Market Size by Sales Channel (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC OTC Anti-Infective Medications Market Size by Region (2016-2021)
  • 6.2 APAC OTC Anti-Infective Medications Market Size by Type (2016-2021)
  • 6.3 APAC OTC Anti-Infective Medications Market Size by Sales Channel (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe OTC Anti-Infective Medications by Country (2016-2021)
  • 7.2 Europe OTC Anti-Infective Medications Market Size by Type (2016-2021)
  • 7.3 Europe OTC Anti-Infective Medications Market Size by Sales Channel (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa OTC Anti-Infective Medications by Region (2016-2021)
  • 8.2 Middle East & Africa OTC Anti-Infective Medications Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa OTC Anti-Infective Medications Market Size by Sales Channel (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global OTC Anti-Infective Medications Market Forecast

  • 10.1 Global OTC Anti-Infective Medications Forecast by Regions (2021-2026)
    • 10.1.1 Global OTC Anti-Infective Medications Forecast by Regions (2021-2026)
    • 10.1.2 Americas OTC Anti-Infective Medications Forecast
    • 10.1.3 APAC OTC Anti-Infective Medications Forecast
    • 10.1.4 Europe OTC Anti-Infective Medications Forecast
    • 10.1.5 Middle East & Africa OTC Anti-Infective Medications Forecast
  • 10.2 Americas OTC Anti-Infective Medications Forecast by Countries (2021-2026)
    • 10.2.1 United States OTC Anti-Infective Medications Market Forecast
    • 10.2.2 Canada OTC Anti-Infective Medications Market Forecast
    • 10.2.3 Mexico OTC Anti-Infective Medications Market Forecast
    • 10.2.4 Brazil OTC Anti-Infective Medications Market Forecast
  • 10.3 APAC OTC Anti-Infective Medications Forecast by Region (2021-2026)
    • 10.3.1 China OTC Anti-Infective Medications Market Forecast
    • 10.3.2 Japan OTC Anti-Infective Medications Market Forecast
    • 10.3.3 Korea OTC Anti-Infective Medications Market Forecast
    • 10.3.4 Southeast Asia OTC Anti-Infective Medications Market Forecast
    • 10.3.5 India OTC Anti-Infective Medications Market Forecast
    • 10.3.6 Australia OTC Anti-Infective Medications Market Forecast
  • 10.4 Europe OTC Anti-Infective Medications Forecast by Country (2021-2026)
    • 10.4.1 Germany OTC Anti-Infective Medications Market Forecast
    • 10.4.2 France OTC Anti-Infective Medications Market Forecast
    • 10.4.3 UK OTC Anti-Infective Medications Market Forecast
    • 10.4.4 Italy OTC Anti-Infective Medications Market Forecast
    • 10.4.5 Russia OTC Anti-Infective Medications Market Forecast
  • 10.5 Middle East & Africa OTC Anti-Infective Medications Forecast by Region (2021-2026)
    • 10.5.1 Egypt OTC Anti-Infective Medications Market Forecast
    • 10.5.2 South Africa OTC Anti-Infective Medications Market Forecast
    • 10.5.3 Israel OTC Anti-Infective Medications Market Forecast
    • 10.5.4 Turkey OTC Anti-Infective Medications Market Forecast
    • 10.5.5 GCC Countries OTC Anti-Infective Medications Market Forecast
  • 10.6 Global OTC Anti-Infective Medications Forecast by Type (2021-2026)
  • 10.7 Global OTC Anti-Infective Medications Forecast by Sales Channel (2021-2026)

11 Key Players Analysis

  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Company Information
    • 11.1.2 GlaxoSmithKline OTC Anti-Infective Medications Product Offered
    • 11.1.3 GlaxoSmithKline OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 GlaxoSmithKline Main Business Overview
    • 11.1.5 GlaxoSmithKline Latest Developments
  • 11.2 Merck
    • 11.2.1 Merck Company Information
    • 11.2.2 Merck OTC Anti-Infective Medications Product Offered
    • 11.2.3 Merck OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 Merck Main Business Overview
    • 11.2.5 Merck Latest Developments
  • 11.3 Pfizer
    • 11.3.1 Pfizer Company Information
    • 11.3.2 Pfizer OTC Anti-Infective Medications Product Offered
    • 11.3.3 Pfizer OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 Pfizer Main Business Overview
    • 11.3.5 Pfizer Latest Developments
  • 11.4 Novartis
    • 11.4.1 Novartis Company Information
    • 11.4.2 Novartis OTC Anti-Infective Medications Product Offered
    • 11.4.3 Novartis OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 Novartis Main Business Overview
    • 11.4.5 Novartis Latest Developments
  • 11.5 Abbott
    • 11.5.1 Abbott Company Information
    • 11.5.2 Abbott OTC Anti-Infective Medications Product Offered
    • 11.5.3 Abbott OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 Abbott Main Business Overview
    • 11.5.5 Abbott Latest Developments
  • 11.6 Sanofi
    • 11.6.1 Sanofi Company Information
    • 11.6.2 Sanofi OTC Anti-Infective Medications Product Offered
    • 11.6.3 Sanofi OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 Sanofi Main Business Overview
    • 11.6.5 Sanofi Latest Developments
  • 11.7 Bristol-Myers Squibb
    • 11.7.1 Bristol-Myers Squibb Company Information
    • 11.7.2 Bristol-Myers Squibb OTC Anti-Infective Medications Product Offered
    • 11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 Bristol-Myers Squibb Main Business Overview
    • 11.7.5 Bristol-Myers Squibb Latest Developments
  • 11.8 Roche
    • 11.8.1 Roche Company Information
    • 11.8.2 Roche OTC Anti-Infective Medications Product Offered
    • 11.8.3 Roche OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 Roche Main Business Overview
    • 11.8.5 Roche Latest Developments
  • 11.9 NanoViricides
    • 11.9.1 NanoViricides Company Information
    • 11.9.2 NanoViricides OTC Anti-Infective Medications Product Offered
    • 11.9.3 NanoViricides OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
    • 11.9.4 NanoViricides Main Business Overview
    • 11.9.5 NanoViricides Latest Developments
  • 11.10 Novabay Pharmaceuticals
    • 11.10.1 Novabay Pharmaceuticals Company Information
    • 11.10.2 Novabay Pharmaceuticals OTC Anti-Infective Medications Product Offered
    • 11.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
    • 11.10.4 Novabay Pharmaceuticals Main Business Overview
    • 11.10.5 Novabay Pharmaceuticals Latest Developments

11. Optimer Pharmaceuticals

  • 11.11.1 Optimer Pharmaceuticals Company Information
  • 11.11.2 Optimer Pharmaceuticals OTC Anti-Infective Medications Product Offered
  • 11.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
  • 11.11.4 Optimer Pharmaceuticals Main Business Overview
  • 11.11.5 Optimer Pharmaceuticals Latest Developments
  • 11.12 Basilea Pharmaceutica
    • 11.12.1 Basilea Pharmaceutica Company Information
    • 11.12.2 Basilea Pharmaceutica OTC Anti-Infective Medications Product Offered
    • 11.12.3 Basilea Pharmaceutica OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
    • 11.12.4 Basilea Pharmaceutica Main Business Overview
    • 11.12.5 Basilea Pharmaceutica Latest Developments
  • 11.13 MerLion Pharma
    • 11.13.1 MerLion Pharma Company Information
    • 11.13.2 MerLion Pharma OTC Anti-Infective Medications Product Offered
    • 11.13.3 MerLion Pharma OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
    • 11.13.4 MerLion Pharma Main Business Overview
    • 11.13.5 MerLion Pharma Latest Developments
  • 12 Research Findings and Conclusion

    Summary:
    Get latest Market Research Reports on OTC Anti-Infective Medications. Industry analysis & Market Report on OTC Anti-Infective Medications is a syndicated market report, published as Global OTC Anti-Infective Medications Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of OTC Anti-Infective Medications market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,772.00
    5,544.00
    3,234.00
    6,468.00
    529,515.00
    1,059,030.00
    291,795.00
    583,590.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report